Linezolida Teva

Linezolid, the active ingredient in Linezolida Teva, is a oxazolidinone antibiotic presented as a tablet for oral use. It treats infections caused by susceptible Gram‑positive bacteria, including MRSA and VRE, in adult patients.

GNH USA supplies Linezolida Teva as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Linezolida Teva is an oxazolidinone antibiotic used to treat serious Gram‑positive bacterial infections. - Community‑acquired pneumonia: effective treatment of bacterial pneumonia caused by susceptible organisms. - Skin and soft‑tissue infections: resolves infections such as cellulitis and wound infections due to susceptible Gram‑positive bacteria. - Infections caused by MRSA and VRE: provides an oral option for infections caused by methicillin‑resistant Staphylococcus aureus and vancomycin‑resistant Enterococcus.

Linezolida Teva may cause a range of adverse reactions, most of which are mild and reversible.

Common Side Effects: - Nausea: mild to moderate stomach upset. - Diarrhea: loose stools occurring during therapy. - Headache: transient cranial discomfort. - Metallic taste: altered taste perception.

Serious or Rare Side Effects: - Thrombocytopenia: significant drop in platelet count. - Peripheral neuropathy: nerve damage presenting as tingling or numbness. - Serotonin syndrome: risk when combined with serotonergic agents.

Before prescribing Linezolida Teva, clinicians should consider several safety aspects. - Renal impairment: adjust monitoring as the drug is partially excreted unchanged. - Hepatic disease: use with caution in patients with liver dysfunction. - Concomitant serotonergic drugs: avoid due to risk of serotonin syndrome. - Hematologic disorders: monitor blood counts for thrombocytopenia or anemia. - Pregnancy and lactation: assess risk‑benefit; limited data are available. - Store at ambient temperature: keep below 25 °C, retain in original packaging, protect from moisture.

Linezolida Teva can interact with other medicines, requiring attention to avoid adverse outcomes.

Major Interactions (Avoid): - Selective serotonin reuptake inhibitors (SSRIs) and monoamine oxidase inhibitors (MAOIs): may precipitate serotonin syndrome. - Rifampicin: induces metabolism, reducing linezolid exposure.

Moderate Interactions (Monitor Closely): - Warfarin: may increase anticoagulant effect; monitor INR. - Ethanol: can enhance central nervous system depression. - MAO‑B inhibitors: potential additive serotonergic effect.